Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,672,859
+$20,203 QoQ
Shares Held
17,055
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#371
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENEDICT FINANCIAL ADVISORS INC holds $49,408,945 across 8 Drug Manufacturers - General names. NVS ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,991 | $15,489,884 | |
| 2 | AMGN |
Amgen Inc
|
33,255 | $12,042,300 | |
| 3 | ABBV |
AbbVie Inc.
|
47,038 | $11,836,642 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
70,088 | $4,038,470 | |
| 5 | NVS |
Novartis AG
This page
|
17,055 | $2,672,859 | |
| 6 | NVO |
Novo Nordisk A S
|
33,754 | $1,618,166 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,812 | $1,492,328 | |
| 8 | LLY |
ELI LILLY & Co
|
182 | $218,296 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,672,859 | 17,055 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,652,656 | 17,366 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,409,691 | 17,478 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $2,246,636 | 17,519 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,128,323 | 17,588 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,942,761 | 17,427 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,637,338 | 16,826 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,939,352 | 16,861 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,830,260 | 17,192 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,645,667 | 17,013 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $1,732,241 | 17,156 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $1,762,178 | 17,300 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,768,548 | 17,526 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,618,924 | 17,597 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,578,346 | 17,398 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,319,077 | 17,354 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,480,373 | 17,513 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,489,556 | 16,975 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,443,779 | 16,506 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,326,389 | 16,219 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,409,475 | 15,448 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,317,161 | 15,409 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,446,762 | 15,321 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,335,357 | 15,356 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,341,193 | 15,356 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $1,267,009 | 15,367 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||